VEGFA and Anxiety: The baseline HRQoL measurements from the treatment naïve nAMD patients may, however, reflect well the effect of nAMD related sudden onset of visual symptoms or anxiety of visual loss in addition to the further effects of anti-VEGF treatment, which supports the composition of the current cohort of newly diagnosed nAMD patients.